About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

KAKEN PHARMACEUTICAL CO.,LTD.(4521) Summary

4521
TSE Prime
KAKEN PHARMACEUTICAL CO.,LTD.
4,257
JPY
+20
(+0.47%)
Dec 23, 3:30 pm JST
27.25
USD
Dec 23, 1:00 am EST
Result
PTS
outside of trading hours
4,259.1
Dec 23, 3:24 pm JST
Summary Chart Historical News Financial Result
PER
11.3
PBR
1.04
Yield
4.46%
Margin Trading Ratio
6.68
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
4,237 JPY 27.06 USD
Previous Close Dec 20
4,237 JPY 27.00 USD
High Dec 23, 10:33 am
4,271 JPY 27.27 USD
Low Dec 23, 9:16 am
4,221 JPY 26.97 USD
Volume
99,600
Trading Value
0.42B JPY 1.92M USD
VWAP
4254.98 JPY 27.15 USD
Minimum Trading Value
425,700 JPY 2,725 USD
Market Cap
0.20T JPY 1.26B USD
Number of Trades
435
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
Slightly High
1-Year Average
581
1-Year High Nov 12, 2024
2,668
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 5,000 68,000 13.60
Dec 6, 2024 4,800 59,400 12.38
Nov 29, 2024 9,100 49,400 5.43
Nov 22, 2024 9,100 60,800 6.68
Nov 15, 2024 7,300 50,400 6.90
Company Profile
KAKEN PHARMACEUTICAL CO.,LTD. is a mid-sized pharmaceutical company. Its main products include joint function improvement agents and onychomycosis medications. The company also develops generic drugs and agricultural chemicals.
Sector
Pharmaceuticals